Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson’s disease in Brazilian patients
Authors:
- Beatriz de Carvalho GuimarãesBGBeatriz de Carvalho Guimarães
- Ana Carolina Valente PereiraAPAna Carolina Valente Pereira
- Fabíola da Costa RodriguesFRFabíola da Costa Rodrigues
- Adriana Vaz dos SantosASAdriana Vaz dos Santos
- Mário Campos JúniorMJMário Campos Júnior
- Jussara Mendonça dos SantosJSJussara Mendonça dos Santos
- Flávia Lima dos SantosFSFlávia Lima dos Santos
- Ana Lúcia Zuma de RossoARAna Lúcia Zuma de Rosso
- Denise Hack NicarettaDNDenise Hack Nicaretta
- João Santos PereiraJPJoão Santos Pereira
- Delson José da SilvaDSDelson José da Silva
- Marcus Vinicius Della ColettaMCMarcus Vinicius Della Coletta
- 23 December 2011
- journal article
- letter
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 18 (5) , 688-689
Abstract
No abstract availableKeywords
Funding Information
- Ministério da Saúde
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 4 references indexed in Scilit:
- Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's diseaseNeuroscience Letters, 2010
- The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body DisordersCurrent Neurology and Neuroscience Reports, 2010
- Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onsetNeurology, 2008
- Association between Parkinson's disease and glucocerebrosidase mutations in BrazilParkinsonism & Related Disorders, 2008